✦ LIBER ✦

Aminobenzisoxazoles with Biaryl P4 Moieties as Potent, Selective, and Orally Bioavailable Factor Xa Inhibitors.

✍ Scribed by Mimi L. Quan; Qi Han; John M. Fevig; Patrick Y. S. Lam; Steve Bai; Robert M. Knabb; Joseph M. Luettgen; Pancras C. Wong; Ruth R. Wexler

Publisher: John Wiley and Sons
Year: 2006
Weight: 24 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200628125

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

1-(2-Naphthyl)-1H-pyrazole-5-carboxylami

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as Potent Factor Xa Inhibitors. Part 3. Design, Synthesis and SAR of Orally Bioavailable Benzamidine-P4 Inhibitors.

✍ Zhaozhong J. Jia; Bing-Yan Zhu; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 81 KB 👁 2 views

ChemInform Abstract: Discovery of Potent

ChemInform Abstract: Discovery of Potent and Long-Acting Oral Factor Xa Inhibitors with Tetrahydroisoquinoline and Benzazepine P4 Motifs.

✍ Robert J. Young; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Preparation of 1-(4-Methoxyphenyl)-1H-py

Preparation of 1-(4-Methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as Potent, Selective and Bioavailable Inhibitors of Coagulation Factor Xa.

✍ John M. Fevig; Joseph Cacciola; Joseph Jr. Buriak; Karen A. Rossi; Robert M. Kna 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 12 KB 👁 1 views

Identification of 4-Piperazin-1-yl-quina

Identification of 4-Piperazin-1-yl-quinazoline Template Based Aryl and Benzyl Thioureas as Potent, Selective, and Orally Bioavailable Inhibitors of Platelet-Derived Growth Factor (PDGF) Receptor.

✍ Julie A. Heath; Mukund M. Mehrotra; Shannon Chi; Jin-Chen Yu; Athiwat Hutchaleel 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 110 KB 👁 1 views

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluor

1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6- [2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl- [1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-on# e (I) (BMS-740808) a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa.

✍ Donald J. P. Pinto; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 10 KB 👁 1 views